FDA Approves ANDA for Verapamil Hydrochloride by Knack
The FDA has approved the ANDA220076 for Verapamil Hydrochloride submitted by Knack.
Therapeutic Area
Therapeutic area intelligence for Calcium Channel Blocker with 6 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
The FDA has accepted a supplemental application for Diltiazem Hydrochloride submitted by Novast Labs.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.